Sinopharm Group Co., Ltd. Class H

Sinopharm Group Co., Ltd. Class H

2.09
USD
-0.10
(-4.47%)
6.67BMarket Cap
Mar 19Next Earn

Total Valuation

USD

As of June 30, 2026, Sinopharm Group Co. Ltd. carries a market capitalization of 6.67B, placing it among publicly traded companies globally. Its enterprise value stands at 21.62B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap6.67B
Enterprise Value21.62B

Important Dates

Sinopharm Group Co. Ltd.'s next confirmed earnings release is scheduled for March 19, 2027.

Earnings Date3/19/2027

Share Statistics

As of June 30, 2026, Sinopharm Group Co. Ltd. has 3.12B shares outstanding.

Shares Outstanding3.12B

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio0.53
P/TBV Ratio0.59

Financial Position

As of June 30, 2026, Sinopharm Group Co. Ltd. maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

Current Ratio1.40
Quick Ratio0.12
Debt / Equity59.64

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count94,910.00

Stock Price Statistics

USD

As of the close on November 16, 2026, Sinopharm Group Co. Ltd.'s stock has declined approximately 17.15% over the past 52 weeks. The 50-day moving average sits at 2.10, while the 200-day moving average is 2.50.

52-Week Price Change-17.15%
50-Day Moving Average2.10
200-Day Moving Average2.50

Balance Sheet

USD

As of June 30, 2026, Sinopharm Group Co. Ltd. holds 4.58B in cash and equivalents against 11.99B in total debt, resulting in a net debt position of 6.87B. Total book value stands at 12.56B, with working capital of 15.20B providing operational flexibility.

Cash & Cash Equivalents4.58B
Total Debt11.99B
Net Debt6.87B
Equity (Book Value)12.56B
Book Value Per Share4.02
Working Capital15.20B